Narendra D. Lalwani
2016
In 2016, Narendra D. Lalwani earned a total compensation of $695.7K as Executive Vice President, Research and Development and Chief Operating Officer at Esperion Therapeutics, a 78% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $85,000 |
|---|---|
| Option Awards | $208,734 |
| Salary | $390,000 |
| Other | $12,000 |
| Total | $695,734 |
Lalwani received $390K in salary, accounting for 56% of the total pay in 2016.
Lalwani also received $85K in non-equity incentive plan, $208.7K in option awards and $12K in other compensation.
Rankings
In 2016, Narendra D. Lalwani's compensation ranked 9,908th out of 14,075 executives tracked by ExecPay. In other words, Lalwani earned more than 29.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,908 out of 14,075 | 30th |
Division Manufacturing | 3,826 out of 5,486 | 30th |
Major group Chemicals And Allied Products | 1,339 out of 1,900 | 30th |
Industry group Drugs | 1,067 out of 1,543 | 31st |
Industry Pharmaceutical Preparations | 838 out of 1,173 | 29th |
Source: SEC filing on March 6, 2017.
Lalwani's colleagues
We found four more compensation records of executives who worked with Narendra D. Lalwani at Esperion Therapeutics in 2016.